Perceptive Advisors

company

Investments

Number of Investments
Number of Lead Investments
44
19
Perceptive Advisors has made 44 investments. Their most recent investment was on Dec 7, 2022, when Apogee Therapeutics, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Dec 7, 2022 Apogee Therapeutics Series B — Biotechnology —
Nov 16, 2022 Biodesix Post-IPO Debt — Biotechnology Yes
Apr 12, 2022 Surf Bio Seed — Biotechnology Yes
Mar 8, 2022 DNAnexus Series H — Bioinformatics —
Dec 7, 2021 Freenome Series D — Biotechnology Yes
Oct 7, 2021 Science 37 Post-IPO Equity — Biotechnology —
Sep 7, 2021 Emulate Series E — Biotechnology —
Sep 1, 2021 SomaLogic Post-IPO Equity — Biotechnology —
Aug 19, 2021 Bridge to Life Ltd. Series Unknown — Biotechnology Yes
Jun 25, 2021 Kindbody Series C — Employee Benefits —
May 13, 2021 Cue Series Unknown — Health Care —
May 12, 2021 Juno Diagnostics Series A — Biotechnology Yes
Apr 29, 2021 Forge Biologics Series B — Biotechnology —
Mar 31, 2021 Scribe Therapeutics Series B — Biotechnology —
Mar 23, 2021 Absci Series Unknown — Artificial Intelligence —
Jan 27, 2021 DarioHealth Post-IPO Equity — Health Care —
Jan 19, 2021 Beam Therapeutics Post-IPO Equity — Biotechnology —
Jan 7, 2021 IsoPlexis Debt Financing — Biotechnology Yes
Jan 7, 2021 IsoPlexis Series D — Biotechnology Yes
Nov 9, 2020 Prometheus Biosciences Private Equity(PE) — Biotechnology —
Sep 22, 2020 Willow Series C — Child Care Yes
Aug 26, 2020 Freenome Series C — Biotechnology Yes
Jul 21, 2020 Forge Biologics Series A — Biotechnology Yes
Jul 8, 2020 Kindbody Series B — Employee Benefits Yes
Jun 9, 2020 DNAnexus Series G — Bioinformatics Yes
Dec 5, 2019 Black Diamond Therapeutics Series C — Biotechnology —
Nov 13, 2019 Avidity Biosciences Series C — Biotechnology —
Jul 24, 2019 Freenome Series B — Biotechnology —
May 6, 2019 Athenex Post-IPO Equity — Biotechnology —
Apr 16, 2019 Kindbody Series A — Employee Benefits Yes
Mar 25, 2019 Saama Series Unknown — Analytics —
Feb 12, 2019 ADMA Biologics Post-IPO Debt — Biotechnology Yes
Jan 9, 2019 Black Diamond Therapeutics Series B — Biotechnology —
Jul 2, 2018 Athenex Post-IPO Equity — Biotechnology Yes
May 18, 2017 Xontogeny Series A — Biopharma Yes
May 16, 2017 Synlogic Series C — Biotechnology —
Dec 1, 2016 Motus GI Series Unknown — Biotechnology Yes
Jul 18, 2016 Ardelyx Post-IPO Equity — Biotechnology —
Jun 2, 2016 VitalConnect Series B — Biotechnology Yes
Jan 8, 2016 Zymeworks Series A — Biotechnology —
Sep 29, 2015 Outlook Therapeutics Series Unknown — Biopharma —
Jul 27, 2015 Outlook Therapeutics Series Unknown — Biopharma Yes
Nov 12, 2014 Blueprint Medicines Series C — Bioinformatics —
Oct 13, 2014 Invitae Series F — Biotechnology —